Caroline Lustenberger

Dr. Caroline Lustenberger

Department of Health Sciences and Technology, ETH Zurich, Zurich 8057, Switzerland

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2016 in Current Biology
Verified
Journal Article
Closed access
Caroline LustenbergerCaroline Lustenberger
Caroline Lustenberger
MBMichael R. Boyle
Michael R. Boyle
SASankaraleengam Alagapan
Sankaraleengam Alagapan
JMJuliann M. Mellin
Juliann M. Mellin
BVBradley V. Vaughn
Bradley V. Vaughn
FFFlavio Fröhlich
Flavio Fröhlich

1 June 2015 in Cortex
Verified
Journal Article
Closed access
Caroline LustenbergerCaroline Lustenberger
Caroline Lustenberger
MBMichael R. Boyle
Michael R. Boyle
AFA. Alban Foulser
A. Alban Foulser
JMJuliann M. Mellin
Juliann M. Mellin
FFFlavio Fröhlich
Flavio Fröhlich

1 June 2018 in European Psychiatry
Verified
Journal Article
Closed access
JMJuliann M. Mellin
Juliann M. Mellin
SASankaraleengam Alagapan
Sankaraleengam Alagapan
Caroline LustenbergerCaroline Lustenberger
Caroline Lustenberger
CLCourtney E. Lugo
Courtney E. Lugo
MAMorgan L. Alexander
Morgan L. Alexander
FFFlavio Fröhlich
Flavio Fröhlich
Background: Approximately 30% of patients with schizophrenia experience auditory hallucinations that are refractory to antipsychotic medications. Here, we evaluated the feasibility and efficacy of transcranial alternating current stimulation (tACS) that we hypothesized would improve auditory hallucination symptoms by enhancing synchronization between the frontal and temporo-parietal areas of the left hemisphere.Method: 22 participants were randomized to one of three arms and received twice daily, 20 min sessions of sham, 10 Hz 2 mA peak-to-peak tACS, or 2 mA tDCS over the course of 5 consecutive days. Symptom improvement was assessed using the Auditory Hallucination Rating Scale (AHRS) as the primary outcome measure. The Positive and Negative Syndrome Scale (PANSS) and the Brief Assessment of Cognition in Schizophrenia (BACS) were secondary outcomes.Results: Primary and secondary behavioral outcomes were not significantly different between the three arms. However, effect size analyses show that tACS had the greatest effect based on the auditory hallucinations scale for the week of stimulation (1.31 for tACS; 1.06 and 0.17, for sham and tDCS, respectively). Effect size analysis for the secondary outcomes revealed heterogeneous results across measures and stimulation conditions.Conclusions: To our knowledge, this is the first clinical trial of tACS for the treatment of symptoms of a psychiatric condition. Further studies with larger sample sizes are needed to better understand the effect of tACS on auditory hallucinations.

1 July 2015 in SLEEP
Verified
Journal Article
Open access
PDF file
Caroline LustenbergerCaroline Lustenberger
Caroline Lustenberger
FWFlavia Wehrle
Flavia Wehrle
LTLaura Tüshaus
Laura Tüshaus
PAPeter Achermann
Peter Achermann
RHReto Huber
Reto Huber
Study Objectives:. Several studies proposed a link between sleep spindles and sleep dependent memory consolidation in declarative learning tasks. In ad

1 January 2019 in NeuroImage
Verified
Journal Article
Closed access
SASankaraleengam Alagapan
Sankaraleengam Alagapan
Caroline LustenbergerCaroline Lustenberger
Caroline Lustenberger
EHEldad Hadar
Eldad Hadar
HSHae Won Shin
Hae Won Shin
FFFlavio Frӧhlich
Flavio Frӧhlich

1 January 2016 in European Psychiatry
Verified
Journal Article
Closed access
FFF. Fröhlich
F. Fröhlich
TBT.N. Burrello
T.N. Burrello
JMJ.M. Mellin
J.M. Mellin
ACA.L. Cordle
A.L. Cordle
Caroline LustenbergerCaroline Lustenberger
Caroline Lustenberger
LJL.F. Jarskog
L.F. Jarskog
Background: Auditory hallucinations are resistant to pharmacotherapy in about 25% of adults with schizophrenia. Treatment with noninvasive brain stimulation would provide a welcomed additional tool for the clinical management of auditory hallucinations. A recent study found a significant reduction in auditory hallucinations in people with schizophrenia after five days of twice-daily transcranial direct current stimulation (tDCS) that simultaneously targeted left dorsolateral prefrontal cortex and left temporo-parietal cortex.Hypothesis: We hypothesized that once-daily tDCS with stimulation electrodes over left frontal and temporo-parietal areas reduces auditory hallucinations in patients with schizophrenia.Methods: We performed a randomized, double-blind, sham-controlled study that evaluated five days of daily tDCS of the same cortical targets in 26 outpatients with schizophrenia and schizoaffective disorder with auditory hallucinations.Results: We found a significant reduction in auditory hallucinations measured by the Auditory Hallucination Rating Scale (F2,50 = 12.22, P < 0.0001) that was not specific to the treatment group (F2,48 = 0.43, P = 0.65). No significant change of overall schizophrenia symptom severity measured by the Positive and Negative Syndrome Scale was observed.Conclusions: The lack of efficacy of tDCS for treatment of auditory hallucinations and the pronounced response in the sham-treated group in this study contrasts with the previous finding and demonstrates the need for further optimization and evaluation of noninvasive brain stimulation strategies. In particular, higher cumulative doses and higher treatment frequencies of tDCS together with strategies to reduce placebo responses should be investigated. Additionally, consideration of more targeted stimulation to engage specific deficits in temporal organization of brain activity in patients with auditory hallucinations may be warranted.